<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30216591</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1098-1004</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>39</Volume>                    <Issue>12</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Dec</Month>                    </PubDate>                </JournalIssue>                <Title>Human mutation</Title>                <ISOAbbreviation>Hum. Mutat.</ISOAbbreviation>            </Journal>            <ArticleTitle>Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial.</ArticleTitle>            <Pagination>                <MedlinePgn>2040-2046</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/humu.23653</ELocationID>            <Abstract>                <AbstractText>The Li-Fraumeni cancer predisposition syndrome (LFS1) presents with a variety of tumor types and the TP53 gene is covered by most diagnostic cancer gene panels. We demonstrate that deleterious TP53 variants identified in blood-derived DNA of 523 patients with ovarian cancer (AGO-TR1 trial) were not causal for the patients' ovarian cancer in three out of six TP53-positive cases. In three out of six patients, deleterious TP53 mutations were identified with low variant fractions in blood-derived DNA but not in the tumor of the patient seeking advice. The analysis of the TP53 and PPM1D genes, both intimately involved in chemotherapy-induced and/or age-related clonal hematopoiesis (CH), in 523 patients and 1,053 age-matched female control individuals revealed that CH represents a frequent event following chemotherapy, affecting 26 of the 523 patients enrolled (5.0%). Considering that TP53 mutations may arise from chemotherapy-induced CH, our findings help to avoid false-positive genetic diagnoses of LFS1.</AbstractText>                <CopyrightInformation>© 2018 Wiley Periodicals, Inc.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Weber-Lassalle</LastName>                    <ForeName>Konstantin</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Harter</LastName>                    <ForeName>Philipp</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gynecology &amp; Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hauke</LastName>                    <ForeName>Jan</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ernst</LastName>                    <ForeName>Corinna</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kommoss</LastName>                    <ForeName>Stefan</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Marmé</LastName>                    <ForeName>Frederik</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weber-Lassalle</LastName>                    <ForeName>Nana</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Prieske</LastName>                    <ForeName>Katharina</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dietrich</LastName>                    <ForeName>Dimo</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Otolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Borde</LastName>                    <ForeName>Julika</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pohl-Rescigno</LastName>                    <ForeName>Esther</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Reuss</LastName>                    <ForeName>Alexander</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Coordinating Center for Clinical Trials, Philipps-University of Marburg, Marburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ataseven</LastName>                    <ForeName>Beyhan</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gynecology &amp; Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Engel</LastName>                    <ForeName>Christoph</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Stingl</LastName>                    <ForeName>Julia C</ForeName>                    <Initials>JC</Initials>                    <AffiliationInfo>                        <Affiliation>Research Division, Federal Institute for Drugs &amp; Medical Devices, Bonn, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schmutzler</LastName>                    <ForeName>Rita K</ForeName>                    <Initials>RK</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hahnen</LastName>                    <ForeName>Eric</ForeName>                    <Initials>E</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1152-8367</Identifier>                    <AffiliationInfo>                        <Affiliation>Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <Agency>Astra Zeneca, Germany</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>16698/68502</GrantID>                    <Agency>Bundesinstitut für Arzneimittel und Medizinprodukte,</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>2016-2020</GrantID>                    <Agency>Bundesinstitut für Arzneimittel und Medizinprodukte,</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>#323-8.0302.16.02-132142</GrantID>                    <Agency>Ministry for Innovation, Science and Research of the State of North Rhine-Westphalia</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>03</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Hum Mutat</MedlineTA>            <NlmUniqueID>9215429</NlmUniqueID>            <ISSNLinking>1059-7794</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Li-Fraumeni syndrome</Keyword>            <Keyword MajorTopicYN="N">PPM1D</Keyword>            <Keyword MajorTopicYN="N">TP53</Keyword>            <Keyword MajorTopicYN="N">chemotherapy</Keyword>            <Keyword MajorTopicYN="N">clonal hematopoiesis</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>12</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>08</Month>                <Day>28</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30216591</ArticleId>            <ArticleId IdType="doi">10.1002/humu.23653</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>